WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today that it has scheduled a webcast and conference call for 8:30 a.m. ET on Thursday, June 12, 2008 to discuss clinical results from a Phase IIa trial of INCB18424 in patients with rheumatoid arthritis that will be presented at the European League Against Rheumatism Congress 2008 currently being held in Paris.
